For US residents only.

Financial Resources

TAFINLAR + MEKINIST

Family

Co-pay Assistance Program

At Novartis Pharmaceuticals Corporation, we are committed to supporting you with your treatment with TAFINLAR® (dabrafenib) + MEKINIST® (trametinib). That is why we developed several assistance programs—to help you access the medicine you need.

 

ELIGIBLE PATIENTS PAY A $10 CO-PAY FOR THEIR TAFINLAR AND MEKINIST PRESCRIPTIONS*

Co-pay card Co-pay card Co-pay card

You may be eligible for immediate co-pay savings on your next prescription of TAFINLAR + MEKINIST. If you are commercially insured, you may complete a 5-minute survey to activate this co-pay offer. If eligible, you may:

  • Pay a $10 co-pay for a 30-day supply of TAFINLAR or MEKINIST
    • Minimum 14-day supply
    • Maximum 90-day supply
  • Save up to the maximum of $15,000 per calendar year on each product
  • Save an unlimited number of times through December 31, 2017

*Limitations apply. This offer is not valid under Medicare, Medicaid, or any other federal or state program, or for cash-paying patients. Novartis reserves the right to rescind, revoke, or amend this program without notice. For full Terms and Conditions, go to www.copay.novartisoncology.com.

Terms and Conditions:
This offer is valid only for those with commercial insurance. Offer not valid under Medicare, Medicaid, or any other federal or state program. Not valid for cash-paying patients, where product is not covered by patient's commercial insurance, or where plan reimburses you for entire cost of your prescription drug. Offer is not valid where prohibited by law. Valid only in the United States and Puerto Rico. This program is not health insurance. Offer may not be combined with any other rebate, coupon, or offer. The card is the property of Novartis Pharmaceuticals Corporation and must be returned upon request. Novartis reserves the right to rescind, revoke, or amend the program without notice. Patient certifies responsibility for complying with applicable limitations, if any, of any commercial insurance and reporting receipt of program rewards, if necessary, to any commercial insurer. This offer expires on December 31, 2017.

Free 30-day Trial

Eligible patients can receive a one-time, per-dose, free 30-day supply of TAFINLAR and MEKINIST for a US Food and Drug Administration–approved indication. Your supply will be shipped directly to you so you can get started with treatment immediately. 

 

Ask your doctor or nurse about the TAFINLAR and MEKINIST 30-day free-trial program. 

Patient Assistance Now Oncology

Patient Assistance Now Oncology

 

Novartis Oncology is committed to helping patients who are living with cancer receive the medicines they need. Patient Assistance Now Oncology (PANO) offers quick and easy access to information about our wide range of resources.

 

You can get information about our PANO support programs in 2 ways:

 

  • Call 1-800-282-7630 to speak with a member of our knowledgeable staff dedicated to making access to therapy as simple and convenient as possible; or
  • Visit our website at: www.OncologyAccessNow.com/patient

 

Here are some of the ways we can help:

 

  • Offer support with insurance verification to help you understand your financial responsibilities and where to get your medicine
  • Assist with changes in your insurance plan when your coverage changes
  • Help you find a pharmacy covered by your plan, and get medication based on your plan guidelines
  • Provide Medicare education
  • Support for Novartis Oncology medication
  • Provide information about financial or co-pay assistance that may be available via independent charitable foundations